Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong · Delayed Price · Currency is HKD 1.210
-0.020 (-1.63%)
May 29, 2026, 4:08 PM HKT
Venus Medtech (Hangzhou) Market Cap
Venus Medtech (Hangzhou) has a market cap or net worth of 529.86 million as of May 29, 2026. Its market cap has decreased by -51.75% in one year.
Market Cap
529.86M
Enterprise Value
477.08M
Revenue
341.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.21
Market Cap Chart
Since December 10, 2019, Venus Medtech (Hangzhou)'s market cap has decreased from 16.91B to 529.86M, a decrease of -96.87%. That is a compound annual growth rate of -41.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 529.86M | -49.16% |
| Dec 31, 2025 | 1.04B | -83.31% |
| Dec 30, 2022 | 6.24B | -51.82% |
| Dec 31, 2021 | 12.96B | -61.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MicroPort CardioFlow Medtech | 2.25B |
| Shanghai HeartCare Medical Technology Corporation | 1.72B |
| Sisram Medical | 1.28B |
| Cryofocus Medtech (Shanghai) | 1.21B |
| Gaush Meditech | 755.70M |
| Vincent Medical Holdings | 540.70M |
| Broncus Holding | 474.37M |
| Austar Lifesciences | 404.94M |